Page last updated: 2024-10-26

stallimycin and Burkitt Lymphoma

stallimycin has been researched along with Burkitt Lymphoma in 1 studies

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG1
Cacciari, B1
Guiotto, A1
Romagnoli, R1
Spalluto, G1
Leoni, A1
Bianchi, N1
Feriotto, G1
Rutigliano, C1
Mischiati, C1
Gambari, R1

Other Studies

1 other study available for stallimycin and Burkitt Lymphoma

ArticleYear
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.
    Nucleosides, nucleotides & nucleic acids, 2000, Volume: 19, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Burkitt Lymphoma; Cell Division; Distamycins; DNA

2000